Proposed issue of securities

Announcement Summary

For personal use only

Entity name

NEUROTECH INTERNATIONAL LIMITED

Announcement Type

New announcement

Date of this announcement

3/3/2022

The Proposed issue is:

A placement or other type of issue

Total number of +securities proposed to be issued for a placement or other type of issue

Maximum Number of

ASX +security code

+Security description

+securities to be issued

New class-code to be

Unlisted Options ($0.08, 10 March 2024)

5,000,000

confirmed

New class-code to be

Unlisted Options ($0.12, 10 March 2024)

5,000,000

confirmed

New class-code to be

Unlisted Options ($0.16,10 March 2024)

5,000,000

confirmed

Proposed +issue date

10/3/2022

Refer to next page for full details of the announcement

Proposed issue of securities

1 / 8

Proposed issue of securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of +Entity

NEUROTECH INTERNATIONAL LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.2

Registered Number Type

Registration Number

ACN

610205402

1.3

ASX issuer code

NTI

1.4 The announcement is

New announcement

1.5

Date of this announcement

3/3/2022

1.6

The Proposed issue is:

A placement or other type of issue

Proposed issue of securities

2 / 8

Proposed issue of securities

Part 7 - Details of proposed placement or other issue

only

Part 7A - Conditions

7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other

type of issue can proceed on an unconditional basis?

use

No

Part 7B - Issue details

Is the proposed security a 'New

Will the proposed issue of this

class' (+securities in a class that is

+security include an offer of

not yet quoted or recorded by ASX)

attaching +securities?

personal

or an 'Existing class' (additional

No

securities in a class that is already

quoted or recorded by ASX)?

New class

Details of +securities proposed to be issued

ISIN Code (if Issuer is a foreign company and +securities are non CDIs)

Have you received confirmation from

Will the entity be seeking quotation

ASX that the terms of the proposed

of the 'new' class of +securities on

+securities are appropriate and

ASX?

equitable under listing rule 6.1?

No

No

ASX +security code

+Security description

New class-code to be confirmed

Unlisted Options ($0.08, 10 March 2024)

For

+Security type

Options

Number of +securities proposed to be issued 5,000,000

Offer price details

Are the +securities proposed to be issued being issued for a cash consideration?

No

Proposed issue of securities

3 / 8

Proposed issue of securities

Please describe the consideration being provided for the +securities

The Company has agreed to issue 5,000,000 options to CEO, Alexandra Andrews, as the first tranche of the equity based component to her remuneration package.

Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities

only

Will all the +securities issued in this class rank equally in all respects from their issue date?

Yes

Options details

use

+Security currency

Exercise price

Expiry date

AUD - Australian Dollar

AUD 0.0800

10/3/2024

Details of the type of +security that will be issued if the option is exercised

NTI : ORDINARY FULLY PAID

personal

Number of securities that will be issued if the option is exercised

not yet quoted or recorded by ASX)

attaching +securities?

One fully paid ordinary share

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities

proposed to be issued or provide the information by separate announcement.

Subject to vesting conditions, the Options will be exercisable at $0.08 and expire two years from their date of issue. The

Options will vest 12 months after the commencement date of Dr Andrews as CEO, subject to Dr Andrews remaining

continually employed by the Company on this date.

Refer to the ASX release dated 3 March 2022 for further information.

Is the proposed security a 'New

Will the proposed issue of this

class' (+securities in a class that is

+security include an offer of

For

or an 'Existing class' (additional

No

securities in a class that is already

quoted or recorded by ASX)? New class

Details of +securities proposed to be issued

ISIN Code (if Issuer is a foreign company and +securities are non CDIs)

Have you received confirmation from

Will the entity be seeking quotation

ASX that the terms of the proposed

of the 'new' class of +securities on

+securities are appropriate and

ASX?

Proposed issue of securities

4 / 8

Proposed issue of securities

equitable under listing rule 6.1?

No

No

ASX +security code

+Security description

New class-code to be confirmed

Unlisted Options ($0.12, 10 March 2024)

only

+Security type

Options

Number of +securities proposed to be issued

5,000,000

Offer price details

use

Are the +securities proposed to be issued being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

The Company has agreed to issue 5,000,000 options to CEO, Alexandra Andrews, as the second tranche of the equity

based component to her remuneration package.

personal

Please provide an estimate of the AUD equivalent of the consideration being

provided for the +securities

NTI : ORDINARY FULLY PAID

Will all the +securities issued in this class rank equally in all respects from

their issue date?

Yes

Options details

+Security currency

Exercise price

Expiry date

AUD - Australian Dollar

AUD 0.1200

10/3/2024

Details of the type of +security that will be issued if the option is exercised

For

Number of securities that will be issued if the option is exercised

One fully paid ordinary share

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities

proposed to be issued or provide the information by separate announcement.

Subject to vesting conditions, the Options will be exercisable at $0.12 and expire two years from their date of issue. The

Options will vest 18 months after the commencement date of Dr Andrews as CEO, subject to Dr Andrews remaining

continually employed by the Company on this date.

Refer to the ASX release dated 3 March 2022 for further information.

Proposed issue of securities

5 / 8

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Neurotech International Ltd. published this content on 03 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 March 2022 07:39:01 UTC.